However, systemic inhibition of TNF production can lead to undesirable side effects due to the weakening of the body’s defenses against pathogens; for example, there are cases of TB reactivation in patients with rheumatoid arthritis treated with TNF blockers [76]. The gene discussed is TNF; the disease is tuberculosis.